Scope of the Report:
This report focuses on the BCG Vaccine Sales in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
BCG vaccine stands for the Bacillus Calmette Guerin vaccine intended for children and adults having high prevalence of tuberculosis (TB). The vaccine prevents from various forms of tuberculosis such as TB meningitis and military.
The worldwide market for BCG Vaccine Sales is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
InterVax
Serum Institute of India
GreenSignal
Statens Serum Institute
Shanyao Group
Shanghai Institute of Biological Products
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immune BCG
Therapy BCG
Market Segment by Applications, can be divided into
Pediatrics
Adults
There are 15 Chapters to deeply display the global BCG Vaccine Sales market.
Chapter 1, to describe BCG Vaccine Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of BCG Vaccine Sales, with sales, revenue, and price of BCG Vaccine Sales, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of BCG Vaccine Sales, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, BCG Vaccine Sales market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe BCG Vaccine Sales sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 BCG Vaccine Sales Introduction
1.2 Market Analysis by Type
1.2.1 Immune BCG
1.2.2 Therapy BCG
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 BCG Vaccine Sales Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi Pasteur
2.2.1 Business Overview
2.2.2 BCG Vaccine Sales Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Pasteur BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Japan BCG Lab
2.3.1 Business Overview
2.3.2 BCG Vaccine Sales Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Japan BCG Lab BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 China National Biotec
2.4.1 Business Overview
2.4.2 BCG Vaccine Sales Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 China National Biotec BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 InterVax
2.5.1 Business Overview
2.5.2 BCG Vaccine Sales Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 InterVax BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Serum Institute of India
2.6.1 Business Overview
2.6.2 BCG Vaccine Sales Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Serum Institute of India BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GreenSignal
2.7.1 Business Overview
2.7.2 BCG Vaccine Sales Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GreenSignal BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Statens Serum Institute
2.8.1 Business Overview
2.8.2 BCG Vaccine Sales Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Statens Serum Institute BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shanyao Group
2.9.1 Business Overview
2.9.2 BCG Vaccine Sales Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Shanyao Group BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shanghai Institute of Biological Products
2.10.1 Business Overview
2.10.2 BCG Vaccine Sales Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shanghai Institute of Biological Products BCG Vaccine Sales Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global BCG Vaccine Sales Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global BCG Vaccine Sales Sales and Market Share by Manufacturer (2016-2017)
3.2 Global BCG Vaccine Sales Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 BCG Vaccine Sales Manufacturer Market Share in 2017
3.3.2 Top 6 BCG Vaccine Sales Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global BCG Vaccine Sales Market Analysis by Regions
4.1 Global BCG Vaccine Sales Sales, Revenue and Market Share by Regions
4.1.1 Global BCG Vaccine Sales Sales and Market Share by Regions (2013-2018)
4.1.2 Global BCG Vaccine Sales Revenue and Market Share by Regions (2013-2018)
4.2 North America BCG Vaccine Sales Sales and Growth Rate (2013-2018)
4.3 Europe BCG Vaccine Sales Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific BCG Vaccine Sales Sales and Growth Rate (2013-2018)
4.5 South America BCG Vaccine Sales Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa BCG Vaccine Sales Sales and Growth Rate (2013-2018)
5 North America BCG Vaccine Sales by Countries
5.1 North America BCG Vaccine Sales Sales, Revenue and Market Share by Countries
5.1.1 North America BCG Vaccine Sales Sales and Market Share by Countries (2013-2018)
5.1.2 North America BCG Vaccine Sales Revenue and Market Share by Countries (2013-2018)
5.2 United States BCG Vaccine Sales Sales and Growth Rate (2013-2018)
5.3 Canada BCG Vaccine Sales Sales and Growth Rate (2013-2018)
5.4 Mexico BCG Vaccine Sales Sales and Growth Rate (2013-2018)
6 Europe BCG Vaccine Sales by Countries
6.1 Europe BCG Vaccine Sales Sales, Revenue and Market Share by Countries
6.1.1 Europe BCG Vaccine Sales Sales and Market Share by Countries (2013-2018)
6.1.2 Europe BCG Vaccine Sales Revenue and Market Share by Countries (2013-2018)
6.2 Germany BCG Vaccine Sales Sales and Growth Rate (2013-2018)
6.3 UK BCG Vaccine Sales Sales and Growth Rate (2013-2018)
6.4 France BCG Vaccine Sales Sales and Growth Rate (2013-2018)
6.5 Russia BCG Vaccine Sales Sales and Growth Rate (2013-2018)
6.6 Italy BCG Vaccine Sales Sales and Growth Rate (2013-2018)
7 Asia-Pacific BCG Vaccine Sales by Countries
7.1 Asia-Pacific BCG Vaccine Sales Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific BCG Vaccine Sales Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific BCG Vaccine Sales Revenue and Market Share by Countries (2013-2018)
7.2 China BCG Vaccine Sales Sales and Growth Rate (2013-2018)
7.3 Japan BCG Vaccine Sales Sales and Growth Rate (2013-2018)
7.4 Korea BCG Vaccine Sales Sales and Growth Rate (2013-2018)
7.5 India BCG Vaccine Sales Sales and Growth Rate (2013-2018)
7.6 Southeast Asia BCG Vaccine Sales Sales and Growth Rate (2013-2018)
8 South America BCG Vaccine Sales by Countries
8.1 South America BCG Vaccine Sales Sales, Revenue and Market Share by Countries
8.1.1 South America BCG Vaccine Sales Sales and Market Share by Countries (2013-2018)
8.1.2 South America BCG Vaccine Sales Revenue and Market Share by Countries (2013-2018)
8.2 Brazil BCG Vaccine Sales Sales and Growth Rate (2013-2018)
8.3 Argentina BCG Vaccine Sales Sales and Growth Rate (2013-2018)
8.4 Colombia BCG Vaccine Sales Sales and Growth Rate (2013-2018)
9 Middle East and Africa BCG Vaccine Sales by Countries
9.1 Middle East and Africa BCG Vaccine Sales Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa BCG Vaccine Sales Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa BCG Vaccine Sales Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia BCG Vaccine Sales Sales and Growth Rate (2013-2018)
9.3 UAE BCG Vaccine Sales Sales and Growth Rate (2013-2018)
9.4 Egypt BCG Vaccine Sales Sales and Growth Rate (2013-2018)
9.5 Nigeria BCG Vaccine Sales Sales and Growth Rate (2013-2018)
9.6 South Africa BCG Vaccine Sales Sales and Growth Rate (2013-2018)
10 Global BCG Vaccine Sales Market Segment by Type
10.1 Global BCG Vaccine Sales Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global BCG Vaccine Sales Sales and Market Share by Type (2013-2018)
10.1.2 Global BCG Vaccine Sales Revenue and Market Share by Type (2013-2018)
10.2 Immune BCG Sales Growth and Price
10.2.1 Global Immune BCG Sales Growth (2013-2018)
10.2.2 Global Immune BCG Price (2013-2018)
10.3 Therapy BCG Sales Growth and Price
10.3.1 Global Therapy BCG Sales Growth (2013-2018)
10.3.2 Global Therapy BCG Price (2013-2018)
11 Global BCG Vaccine Sales Market Segment by Application
11.1 Global BCG Vaccine Sales Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adults Sales Growth (2013-2018)
12 BCG Vaccine Sales Market Forecast (2018-2023)
12.1 Global BCG Vaccine Sales Sales, Revenue and Growth Rate (2018-2023)
12.2 BCG Vaccine Sales Market Forecast by Regions (2018-2023)
12.2.1 North America BCG Vaccine Sales Market Forecast (2018-2023)
12.2.2 Europe BCG Vaccine Sales Market Forecast (2018-2023)
12.2.3 Asia-Pacific BCG Vaccine Sales Market Forecast (2018-2023)
12.2.4 South America BCG Vaccine Sales Market Forecast (2018-2023)
12.2.5 Middle East and Africa BCG Vaccine Sales Market Forecast (2018-2023)
12.3 BCG Vaccine Sales Market Forecast by Type (2018-2023)
12.3.1 Global BCG Vaccine Sales Sales Forecast by Type (2018-2023)
12.3.2 Global BCG Vaccine Sales Market Share Forecast by Type (2018-2023)
12.4 BCG Vaccine Sales Market Forecast by Application (2018-2023)
12.4.1 Global BCG Vaccine Sales Sales Forecast by Application (2018-2023)
12.4.2 Global BCG Vaccine Sales Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure BCG Vaccine Sales Picture
Table Product Specifications of BCG Vaccine Sales
Figure Global Sales Market Share of BCG Vaccine Sales by Types in 2017
Table